These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26695431)

  • 1. The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development.
    Morrow Guthrie K; Vargas S; Shaw JG; Rosen RK; van den Berg JJ; Kiser PF; Buckheit K; Bregman D; Thompson L; Jensen K; Johnson T; Buckheit RW
    PLoS One; 2015; 10(12):e0145642. PubMed ID: 26695431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.
    Rosen RK; van den Berg JJ; Vargas SE; Senocak N; Shaw JG; Buckheit RW; Smith KA; Guthrie KM
    Contraception; 2015 Dec; 92(6):596-601. PubMed ID: 26276246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.
    Guthrie KM; Rosen RK; Vargas SE; Getz ML; Dawson L; Guillen M; Ramirez JJ; Baum MM; Vincent KL
    PLoS One; 2018; 13(5):e0197269. PubMed ID: 29758049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019.
    McLellan-Lemal E; Deaton SR; Betts JE; Ondenge K; Mudhune V; O'Connor SM; Nyagol B; Thurman AR; Doncel GF; Allen SA; Heffron R; Mugo NR;
    Contemp Clin Trials; 2022 Nov; 122():106935. PubMed ID: 36162740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
    Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
    J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic.
    Tolley EE; Zissette S; Taylor J; Hanif H; Ju S; Schwarz J; Thurman A; Tyner D; Brache V; Doncel GF
    J Womens Health (Larchmt); 2022 Sep; 31(9):1343-1352. PubMed ID: 35363574
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.
    Friend DR
    Expert Opin Drug Deliv; 2016; 13(4):533-45. PubMed ID: 26742698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.
    Thurman AR; Clark MR; Hurlburt JA; Doncel GF
    Int J Womens Health; 2013 Oct; 5():695-708. PubMed ID: 24174884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
    Clark JT; Clark MR; Shelke NB; Johnson TJ; Smith EM; Andreasen AK; Nebeker JS; Fabian J; Friend DR; Kiser PF
    PLoS One; 2014; 9(3):e88509. PubMed ID: 24599325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials.
    Hawley I; Song M; Scheckter R; McClure T; Piper J; Chen BA; Hoesley C; Liu AY; van der Straten A
    AIDS Res Hum Retroviruses; 2022 Apr; 38(4):313-326. PubMed ID: 34969254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
    Friend DR
    Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.
    Gupta KM; Pearce SM; Poursaid AE; Aliyar HA; Tresco PA; Mitchnik MA; Kiser PF
    J Pharm Sci; 2008 Oct; 97(10):4228-39. PubMed ID: 18338805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.
    Su JT; Teller RS; Srinivasan P; Zhang J; Martin A; Sung S; Smith JM; Kiser PF
    Pharm Res; 2017 Oct; 34(10):2163-2171. PubMed ID: 28770490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.
    Moss JA; Butkyavichene I; Churchman SA; Gunawardana M; Fanter R; Miller CS; Yang F; Easley JT; Marzinke MA; Hendrix CW; Smith TJ; Baum MM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3759-66. PubMed ID: 27067321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness.
    Guthrie KM; Rosen RK; Vargas SE; Guillen M; Steger AL; Getz ML; Smith KA; Ramirez JJ; Kojic EM
    Drug Deliv Transl Res; 2017 Oct; 7(5):761-770. PubMed ID: 28653286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent work on vaginal rings containing antiviral agents for HIV prevention.
    Spence P; Bhatia Garg A; Woodsong C; Devin B; Rosenberg Z
    Curr Opin HIV AIDS; 2015 Jul; 10(4):264-70. PubMed ID: 26049952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
    Brady M; Manning J
    Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical testing methods for drug-releasing vaginal rings.
    McCoy CF; Millar BG; Murphy DJ; Blanda W; Hansraj B; Devlin B; Malcolm RK; Boyd P
    Int J Pharm; 2019 Mar; 559():182-191. PubMed ID: 30668990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New delivery systems in contraception: vaginal rings.
    Johansson ED; Sitruk-Ware R
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S54-9. PubMed ID: 15105799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.